Cargando…
Challenges and Opportunities in the Crusade of BRAF Inhibitors: From 2002 to 2022
[Image: see text] Serine/threonine-protein kinase B-Raf (BRAF; RAF = rapidly accelerated fibrosarcoma) plays an important role in the mitogen-activated protein kinase (MAPK) signaling cascade. Somatic mutations in the BRAF gene were first discovered in 2002 by Davies et al., which was a major breakt...
Autores principales: | Singh, Ankit Kumar, Sonawane, Pankaj, Kumar, Adarsh, Singh, Harshwardhan, Naumovich, Vladislav, Pathak, Prateek, Grishina, Maria, Khalilullah, Habibullah, Jaremko, Mariusz, Emwas, Abdul-Hamid, Verma, Amita, Kumar, Pradeep |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Chemical Society
2023
|
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10413849/ https://www.ncbi.nlm.nih.gov/pubmed/37576670 http://dx.doi.org/10.1021/acsomega.3c00332 |
Ejemplares similares
-
Concept of Hybrid Drugs and Recent Advancements in Anticancer Hybrids
por: Singh, Ankit Kumar, et al.
Publicado: (2022) -
Gaussian field-based 3D-QSAR and molecular simulation studies to design potent pyrimidine–sulfonamide hybrids as selective BRAF(V600E) inhibitors
por: Singh, Ankit Kumar, et al.
Publicado: (2022) -
Nitrogen Containing Heterocycles as Anticancer Agents: A Medicinal Chemistry Perspective
por: Kumar, Adarsh, et al.
Publicado: (2023) -
Medicinal chemistry perspective of pyrido[2,3-d]pyrimidines as anticancer agents
por: Kumar, Adarsh, et al.
Publicado: (2023) -
Guava Leaf Essential Oil as a Potent Antioxidant and Anticancer Agent: Validated through Experimental and Computational Study
por: Mandal, Ashok Kumar, et al.
Publicado: (2022)